Board Experience - Previous
Companies with which I have been involved at board level have generally met their corporate objectives. Three companies with which I have been associated (PowderJect, Vectura and Cozart) have achieved sucessful listings on the LSE whilst several others including Incenta, Paradigm, Sterix and CTM Biotech have been acquired . Others including Avlar - which raised a £40m plus second VC fund, Adjuvantix and Pro-Cure have gone on to raise further investment.
| Company | Activities | Context | Dates |
|---|---|---|---|
| PowderJect Limited | Finance & Operations Director | Board Level position | 1996-1997 |
| Vectura | Managing Director | Founder | 1997 to 2000 |
| Co-ordinated Drug Development | Director | Company acquired by Vectura | 1999 to 2000 |
| Avlar BioVentures | Chief Executive | Joined in consulting role ultimately becoming CEO | 2000 to 2002 |
| Incenta | Non Executive Director | Avlar investee company | 2000 to 2002 |
| Paradigm Therapeutics | Non Executive Director | Avlar investee company | 2000 to 2002 |
| Sterix | Non Executive Director | Avlar investee company | 2001 to 2002 |
| Cozart | Board Observor | Avlar investee company | 2001 to 2002 |
| Iceni BioDiscovery | Chairman | Founding investment by Avlar | 2001 to 2002 |
| Medical Device Innovations | Director | Founding investment by Avlar | 2001 to 2002 |
| Proteom | Chairman | Investment by Avlar | 2002 |
| Pro-Cure Therapeutics | Non Executive Director | White Rose Technology Seed Fund nominee | 2002 to 2006 |
| Adjuvantix | Chairman | Non executive role | 2003 to 2006 |
| MultiProSys | Non Executive Director | Babraham Bioconcepts nominee | 2005 |
| CTM Biotech Limited | Chairman | Founder | 2003 to 2007 |
| Sports Dynamics Limited | Non Executive Director & Company Secretary | Lachesis Fund nominee | 2005 to 2008 |
| Equinox Pharma Limited | Chief Executive | Executive responsibility to the board | 2006 to 2009 |
